GIC to invest US$1B for stake in Grifols’ US subsidiary Biomat USA
GIC plans to invest around US$1B to acquire a minority stake in Biomat USA, a U.S. subsidiary of Spanish pharmaceutical company Grifols.
GIC plans to invest around US$1B to acquire a minority stake in Biomat USA, a U.S. subsidiary of Spanish pharmaceutical company Grifols.